| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $-0.03 (Beat by $0.1) |
| EPS GAAP Actual | $-0.03 (Beat by $0.1) |
| Revenue Actual | $1.458B |
| Revenue Surprise | Beat by $1458M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.4603 |
| EPS GAAP Estimate | $0.4603 |
| Revenue Estimate | $1.756029643B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 0 | INF | 0 | 0 | 0 |
| Dec 2026 | -2.70759 | -3.11 | -2.97142 | -2.48495 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -0.92 | -1.44 | 1.458B | -7.96% | -351.11M |
| FQ1 2025 (Mar 2025) | -0.03 | -0.03 | 1.41B | -4.26% | 1410M |
| FQ4 2024 (Dec 2024) | -0.82 | -0.82 | 1.452B | 3.37% | 1452M |
| FQ3 2024 (Sep 2024) | 0.42 | 0.42 | 1.54B | 2.21% | 1540M |
| FQ2 2024 (Jun 2024) | 0.13 | 0.13 | 1.574B | -1.4% | 1574M |
| FQ1 2024 (Mar 2024) | -0.22 | -0.22 | 1.47B | -9.25% | 1470M |
| FQ4 2023 (Dec 2023) | -0.41 | -0.41 | 1.403B | 100% | 1403M |
| FQ3 2023 (Sep 2023) | 0.39 | 0.39 | 1.506B | -33.53% | 1506M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.4603
Consensus Revenue Estimates
1.756029643B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.03613 | -- | 0.03607977 | 0.03618023 | 6 |
| FQ3 2027 (Sep 2027) | 0.18587 | -- | 0.17884 | 0.19532 | 7 |
| FQ2 2027 (Jun 2027) | 0.23397 | -- | 0.22512 | 0.24586 | 6 |
| FQ1 2027 (Mar 2027) | 0.12364 | -- | 0.12347 | 0.12381 | 9 |
| FQ4 2026 (Oct 2026) | 0.58122 | -- | 0.51462 | 0.62309 | 7 |
| FQ3 2026 (Jul 2026) | 0.61764 | -- | 0.54686 | 0.66214 | 4 |
| FQ2 2026 (Jun 2026) | 0.61764 | 248.95 | 0.54396 | 0.65307 | 4 |
| FQ1 2026 (Mar 2026) | 0.48941 | 106.13 | 0.43103 | 0.51748 | 4 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.55B | -- | 1.55B | 1.56B | 1 |
| FQ3 2027 (Sep 2027) | 1.5B | -- | 1.46B | 1.56B | 9 |
| FQ2 2027 (Jun 2027) | 1.49B | -- | 1.45B | 1.55B | 6 |
| FQ1 2027 (Mar 2027) | 1.52B | -- | 1.52B | 1.53B | 1 |
| FQ4 2026 (Oct 2026) | 1.47B | -- | 1.34B | 1.55B | 5 |
| FQ3 2026 (Jul 2026) | 1.47B | -- | 1.34B | 1.55B | 5 |
| FQ2 2026 (Jun 2026) | 1.4B | -3.87 | 1.27B | 1.47B | 5 |
| FQ1 2026 (Mar 2026) | 1.4B | -0.45 | 1.27B | 1.47B | 5 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.52 | -0.92 | -1.44 | 156.52% |
| FQ1 2025 (Mar 2025) | -0.03 | -0.03 | 100% | |
| FQ4 2024 (Dec 2024) | -0.82 | -0.82 | 100% | |
| FQ3 2024 (Sep 2024) | 0.42 | 0.42 | 100% | |
| FQ2 2024 (Jun 2024) | 0.13 | 0.13 | 100% | |
| FQ1 2024 (Mar 2024) | -0.22 | -0.22 | 100% | |
| FQ4 2023 (Dec 2023) | -0.41 | -0.41 | 100% | |
| FQ3 2023 (Sep 2023) | 0.39 | 0.39 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $1.81B | $1.46B | $-351.11M | -24.08% |
| FQ1 2025 (Mar 2025) | $0B | $1.41B | $1410M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.45B | $1452M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.54B | $1540M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.57B | $1574M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.47B | $1470M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.4B | $1403M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $1.51B | $1506M | 100% |